172.41MMarket Cap-1850P/E (TTM)
7.820High7.290Low225.34KVolume7.620Open7.540Pre Close1.69MTurnover2.04%Turnover RatioLossP/E (Static)23.30MShares40.60052wk High-7.08P/B81.89MFloat Cap4.00452wk Low--Dividend TTM11.07MShs Float219.200Historical High--Div YieldTTM7.03%Amplitude4.004Historical Low7.479Avg Price1Lot Size
Outlook Therapeutics Stock Forum
$Outlook Therapeutics(OTLK.US)$ is another.
In an era where medical advancements are pivotal to enhancing quality of life, a significant breakthrough has been made in the treatment of wet age-related macular degeneration (AMD), a leading cause of vision loss among the elderly. Outlook Therapeutics, Inc. has received a positive opinion from the European Union's Committee for Me...
No comment yet